<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Balancing on Longetivities</title><link>https://longetivities.com/tags/balancing/</link><description>Recent content in Balancing on Longetivities</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Thu, 16 Apr 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://longetivities.com/tags/balancing/feed.xml" rel="self" type="application/rss+xml"/><item><title>Sirtuins vs mTOR: Balancing Longevity Pathways</title><link>https://longetivities.com/blog/sirtuins-vs-mtor-balancing-longevity-pathways/</link><pubDate>Wed, 11 Feb 2026 00:00:00 +0000</pubDate><guid>https://longetivities.com/blog/sirtuins-vs-mtor-balancing-longevity-pathways/</guid><description>&lt;blockquote&gt;
&lt;p&gt;&lt;strong&gt;Cluster context:&lt;/strong&gt; This article belongs to the &lt;strong&gt;Head-to-Head Protocol Comparisons&lt;/strong&gt; cluster. For the broader overview, start with &lt;a href="https://longetivities.com/blog/compare-longevity-protocols-practical-framework-for-low-risk-biohacking/"&gt;Compare Longevity Protocols: Practical Framework For Low-Risk Biohacking&lt;/a&gt;.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;The debate between sirtuins and mTOR represents one of the most consequential discussions in modern longevity research. These two molecular systems operate as opposing forces within your cells—one promoting growth when nutrients abound, the other activating cellular repair when resources become scarce.&lt;/p&gt;
&lt;p&gt;For researchers, clinicians, and health professionals working to translate bench findings into healthspan-extending interventions, understanding this dynamic is essential. The tension between these pathways shapes nearly every aspect of the aging process, from metabolic syndrome to neurodegeneration.&lt;/p&gt;</description></item></channel></rss>